nodes	percent_of_prediction	percent_of_DWPC	metapath
Vincristine—ABCG2—Leflunomide—systemic scleroderma	0.103	0.154	CbGbCtD
Vincristine—ABCC10—Methotrexate—systemic scleroderma	0.0989	0.148	CbGbCtD
Vincristine—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.0705	0.105	CbGbCtD
Vincristine—ABCG2—Mycophenolate mofetil—systemic scleroderma	0.0637	0.0952	CbGbCtD
Vincristine—ABCC3—Methotrexate—systemic scleroderma	0.0622	0.0929	CbGbCtD
Vincristine—ABCB1—Lisinopril—systemic scleroderma	0.039	0.0582	CbGbCtD
Vincristine—ABCC1—Methotrexate—systemic scleroderma	0.0382	0.0571	CbGbCtD
Vincristine—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0353	0.0527	CbGbCtD
Vincristine—ABCB1—Captopril—systemic scleroderma	0.0292	0.0436	CbGbCtD
Vincristine—ABCC2—Methotrexate—systemic scleroderma	0.0283	0.0422	CbGbCtD
Vincristine—ABCG2—Methotrexate—systemic scleroderma	0.0256	0.0382	CbGbCtD
Vincristine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.023	0.0343	CbGbCtD
Vincristine—ABCB1—Prednisone—systemic scleroderma	0.0184	0.0274	CbGbCtD
Vincristine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0138	0.0206	CbGbCtD
Vincristine—CYP3A4—Prednisone—systemic scleroderma	0.011	0.0164	CbGbCtD
Vincristine—ABCB1—Methotrexate—systemic scleroderma	0.00921	0.0138	CbGbCtD
Vincristine—TUBB3—connective tissue—systemic scleroderma	0.00295	0.0376	CbGeAlD
Vincristine—NR0B1—lung—systemic scleroderma	0.00243	0.0309	CbGeAlD
Vincristine—TUBA4A—connective tissue—systemic scleroderma	0.00224	0.0285	CbGeAlD
Vincristine—TUBB3—digestive system—systemic scleroderma	0.00213	0.0271	CbGeAlD
Vincristine—TUBA4A—smooth muscle tissue—systemic scleroderma	0.00205	0.0261	CbGeAlD
Vincristine—TUBA4A—skin of body—systemic scleroderma	0.00202	0.0258	CbGeAlD
Vincristine—RALBP1—smooth muscle tissue—systemic scleroderma	0.00193	0.0246	CbGeAlD
Vincristine—TUBB4A—connective tissue—systemic scleroderma	0.0018	0.0229	CbGeAlD
Vincristine—TUBB3—lung—systemic scleroderma	0.00178	0.0227	CbGeAlD
Vincristine—TUBB2B—connective tissue—systemic scleroderma	0.00174	0.0221	CbGeAlD
Vincristine—TUBB2A—connective tissue—systemic scleroderma	0.00163	0.0208	CbGeAlD
Vincristine—TUBB4A—skin of body—systemic scleroderma	0.00162	0.0207	CbGeAlD
Vincristine—TUBA4A—digestive system—systemic scleroderma	0.00162	0.0206	CbGeAlD
Vincristine—ABCB11—digestive system—systemic scleroderma	0.00161	0.0205	CbGeAlD
Vincristine—TUBA4A—tendon—systemic scleroderma	0.00154	0.0196	CbGeAlD
Vincristine—RALBP1—digestive system—systemic scleroderma	0.00153	0.0194	CbGeAlD
Vincristine—TUBB—smooth muscle tissue—systemic scleroderma	0.0015	0.0191	CbGeAlD
Vincristine—TUBB2A—smooth muscle tissue—systemic scleroderma	0.00149	0.019	CbGeAlD
Vincristine—TUBB2A—skin of body—systemic scleroderma	0.00148	0.0188	CbGeAlD
Vincristine—TUBB6—smooth muscle tissue—systemic scleroderma	0.00147	0.0188	CbGeAlD
Vincristine—TUBB6—skin of body—systemic scleroderma	0.00145	0.0185	CbGeAlD
Vincristine—RALBP1—tendon—systemic scleroderma	0.00145	0.0185	CbGeAlD
Vincristine—TUBB4B—connective tissue—systemic scleroderma	0.0014	0.0178	CbGeAlD
Vincristine—TUBA4A—lung—systemic scleroderma	0.00135	0.0172	CbGeAlD
Vincristine—TUBB4A—digestive system—systemic scleroderma	0.0013	0.0165	CbGeAlD
Vincristine—TUBB4B—smooth muscle tissue—systemic scleroderma	0.00128	0.0163	CbGeAlD
Vincristine—RALBP1—lung—systemic scleroderma	0.00127	0.0162	CbGeAlD
Vincristine—TUBB4B—skin of body—systemic scleroderma	0.00126	0.0161	CbGeAlD
Vincristine—TUBB2B—digestive system—systemic scleroderma	0.00125	0.016	CbGeAlD
Vincristine—TUBB4A—tendon—systemic scleroderma	0.00123	0.0157	CbGeAlD
Vincristine—SLC22A3—connective tissue—systemic scleroderma	0.00121	0.0154	CbGeAlD
Vincristine—TUBB2B—tendon—systemic scleroderma	0.00119	0.0152	CbGeAlD
Vincristine—TUBB2A—digestive system—systemic scleroderma	0.00118	0.015	CbGeAlD
Vincristine—TUBB6—digestive system—systemic scleroderma	0.00116	0.0148	CbGeAlD
Vincristine—TUBB—tendon—systemic scleroderma	0.00113	0.0144	CbGeAlD
Vincristine—TUBB2A—tendon—systemic scleroderma	0.00112	0.0143	CbGeAlD
Vincristine—TUBB6—tendon—systemic scleroderma	0.00111	0.0141	CbGeAlD
Vincristine—SLC22A3—smooth muscle tissue—systemic scleroderma	0.0011	0.0141	CbGeAlD
Vincristine—TUBB4A—lung—systemic scleroderma	0.00108	0.0138	CbGeAlD
Vincristine—TUBB2B—lung—systemic scleroderma	0.00105	0.0133	CbGeAlD
Vincristine—ABCC3—digestive system—systemic scleroderma	0.00102	0.013	CbGeAlD
Vincristine—ABCC10—digestive system—systemic scleroderma	0.00102	0.013	CbGeAlD
Vincristine—TUBB4B—digestive system—systemic scleroderma	0.00101	0.0129	CbGeAlD
Vincristine—TUBB—lung—systemic scleroderma	0.000991	0.0126	CbGeAlD
Vincristine—TUBB2A—lung—systemic scleroderma	0.000985	0.0126	CbGeAlD
Vincristine—TUBB6—lung—systemic scleroderma	0.000972	0.0124	CbGeAlD
Vincristine—ABCC10—tendon—systemic scleroderma	0.00097	0.0124	CbGeAlD
Vincristine—TUBB4B—tendon—systemic scleroderma	0.000963	0.0123	CbGeAlD
Vincristine—ABCC3—lung—systemic scleroderma	0.000855	0.0109	CbGeAlD
Vincristine—ABCC10—lung—systemic scleroderma	0.000851	0.0108	CbGeAlD
Vincristine—TUBB4B—lung—systemic scleroderma	0.000845	0.0108	CbGeAlD
Vincristine—ABCC2—digestive system—systemic scleroderma	0.000818	0.0104	CbGeAlD
Vincristine—ABCB1—blood vessel—systemic scleroderma	0.000794	0.0101	CbGeAlD
Vincristine—ABCC2—tendon—systemic scleroderma	0.000779	0.00992	CbGeAlD
Vincristine—SLC22A3—lung—systemic scleroderma	0.000728	0.00927	CbGeAlD
Vincristine—ABCC1—tendon—systemic scleroderma	0.000686	0.00874	CbGeAlD
Vincristine—ABCC1—lung—systemic scleroderma	0.000602	0.00767	CbGeAlD
Vincristine—CYP3A5—digestive system—systemic scleroderma	0.000554	0.00705	CbGeAlD
Vincristine—ABCG2—lung—systemic scleroderma	0.000498	0.00635	CbGeAlD
Vincristine—CYP3A5—lung—systemic scleroderma	0.000463	0.00589	CbGeAlD
Vincristine—CYP3A4—digestive system—systemic scleroderma	0.000416	0.00529	CbGeAlD
Vincristine—Gastrointestinal pain—Captopril—systemic scleroderma	0.000354	0.0014	CcSEcCtD
Vincristine—Asthenia—Mometasone—systemic scleroderma	0.000354	0.0014	CcSEcCtD
Vincristine—Hypotension—Azathioprine—systemic scleroderma	0.000353	0.0014	CcSEcCtD
Vincristine—Polyuria—Methotrexate—systemic scleroderma	0.000353	0.0014	CcSEcCtD
Vincristine—Cardiac arrest—Prednisone—systemic scleroderma	0.000352	0.0014	CcSEcCtD
Vincristine—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000351	0.00139	CcSEcCtD
Vincristine—Nervous system disorder—Leflunomide—systemic scleroderma	0.00035	0.00139	CcSEcCtD
Vincristine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00035	0.00138	CcSEcCtD
Vincristine—Anaemia—Lisinopril—systemic scleroderma	0.000347	0.00138	CcSEcCtD
Vincristine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000345	0.00137	CcSEcCtD
Vincristine—Hepatic failure—Methotrexate—systemic scleroderma	0.000345	0.00137	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000344	0.00136	CcSEcCtD
Vincristine—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.000343	0.00136	CcSEcCtD
Vincristine—Abdominal pain—Captopril—systemic scleroderma	0.000342	0.00136	CcSEcCtD
Vincristine—Body temperature increased—Captopril—systemic scleroderma	0.000342	0.00136	CcSEcCtD
Vincristine—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000341	0.00135	CcSEcCtD
Vincristine—Oedema—Mycophenolic acid—systemic scleroderma	0.000341	0.00135	CcSEcCtD
Vincristine—Anorexia—Leflunomide—systemic scleroderma	0.00034	0.00135	CcSEcCtD
Vincristine—Nausea—Pentoxifylline—systemic scleroderma	0.000339	0.00135	CcSEcCtD
Vincristine—Infection—Mycophenolic acid—systemic scleroderma	0.000338	0.00134	CcSEcCtD
Vincristine—Vertigo—Lisinopril—systemic scleroderma	0.000338	0.00134	CcSEcCtD
Vincristine—Diarrhoea—Mometasone—systemic scleroderma	0.000337	0.00134	CcSEcCtD
Vincristine—Leukopenia—Lisinopril—systemic scleroderma	0.000336	0.00133	CcSEcCtD
Vincristine—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000334	0.00132	CcSEcCtD
Vincristine—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000334	0.00132	CcSEcCtD
Vincristine—Hypotension—Leflunomide—systemic scleroderma	0.000334	0.00132	CcSEcCtD
Vincristine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000333	0.00132	CcSEcCtD
Vincristine—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000331	0.00131	CcSEcCtD
Vincristine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000329	0.0013	CcSEcCtD
Vincristine—Muscular weakness—Prednisone—systemic scleroderma	0.000327	0.0013	CcSEcCtD
Vincristine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000326	0.00129	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000325	0.00129	CcSEcCtD
Vincristine—Anorexia—Mycophenolic acid—systemic scleroderma	0.000325	0.00129	CcSEcCtD
Vincristine—Insomnia—Leflunomide—systemic scleroderma	0.000323	0.00128	CcSEcCtD
Vincristine—Paraesthesia—Leflunomide—systemic scleroderma	0.000321	0.00127	CcSEcCtD
Vincristine—Myalgia—Lisinopril—systemic scleroderma	0.00032	0.00127	CcSEcCtD
Vincristine—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000319	0.00126	CcSEcCtD
Vincristine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000318	0.00126	CcSEcCtD
Vincristine—Vomiting—Mometasone—systemic scleroderma	0.000314	0.00124	CcSEcCtD
Vincristine—Rash—Mometasone—systemic scleroderma	0.000311	0.00123	CcSEcCtD
Vincristine—Asthenia—Captopril—systemic scleroderma	0.000311	0.00123	CcSEcCtD
Vincristine—Dermatitis—Mometasone—systemic scleroderma	0.000311	0.00123	CcSEcCtD
Vincristine—Decreased appetite—Leflunomide—systemic scleroderma	0.00031	0.00123	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00031	0.00123	CcSEcCtD
Vincristine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000309	0.00122	CcSEcCtD
Vincristine—Headache—Mometasone—systemic scleroderma	0.000309	0.00122	CcSEcCtD
Vincristine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000308	0.00122	CcSEcCtD
Vincristine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000308	0.00122	CcSEcCtD
Vincristine—Fatigue—Leflunomide—systemic scleroderma	0.000308	0.00122	CcSEcCtD
Vincristine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000307	0.00122	CcSEcCtD
Vincristine—Oedema—Lisinopril—systemic scleroderma	0.000307	0.00122	CcSEcCtD
Vincristine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000306	0.00121	CcSEcCtD
Vincristine—Pain—Leflunomide—systemic scleroderma	0.000305	0.00121	CcSEcCtD
Vincristine—Constipation—Leflunomide—systemic scleroderma	0.000305	0.00121	CcSEcCtD
Vincristine—Infection—Lisinopril—systemic scleroderma	0.000305	0.00121	CcSEcCtD
Vincristine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000304	0.00121	CcSEcCtD
Vincristine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000303	0.0012	CcSEcCtD
Vincristine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.0003	0.00119	CcSEcCtD
Vincristine—Neutropenia—Prednisone—systemic scleroderma	0.0003	0.00119	CcSEcCtD
Vincristine—Abdominal pain—Azathioprine—systemic scleroderma	0.000299	0.00118	CcSEcCtD
Vincristine—Body temperature increased—Azathioprine—systemic scleroderma	0.000299	0.00118	CcSEcCtD
Vincristine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000297	0.00118	CcSEcCtD
Vincristine—Diarrhoea—Captopril—systemic scleroderma	0.000296	0.00117	CcSEcCtD
Vincristine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000296	0.00117	CcSEcCtD
Vincristine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000296	0.00117	CcSEcCtD
Vincristine—Erectile dysfunction—Prednisone—systemic scleroderma	0.000295	0.00117	CcSEcCtD
Vincristine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000295	0.00117	CcSEcCtD
Vincristine—ABCB1—digestive system—systemic scleroderma	0.000294	0.00375	CbGeAlD
Vincristine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000294	0.00117	CcSEcCtD
Vincristine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000294	0.00116	CcSEcCtD
Vincristine—Nausea—Mometasone—systemic scleroderma	0.000293	0.00116	CcSEcCtD
Vincristine—Anorexia—Lisinopril—systemic scleroderma	0.000292	0.00116	CcSEcCtD
Vincristine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000292	0.00116	CcSEcCtD
Vincristine—Ataxia—Methotrexate—systemic scleroderma	0.000291	0.00115	CcSEcCtD
Vincristine—Pain—Mycophenolic acid—systemic scleroderma	0.000291	0.00115	CcSEcCtD
Vincristine—Constipation—Mycophenolic acid—systemic scleroderma	0.000291	0.00115	CcSEcCtD
Vincristine—Weight decreased—Prednisone—systemic scleroderma	0.00029	0.00115	CcSEcCtD
Vincristine—Hypotension—Lisinopril—systemic scleroderma	0.000287	0.00114	CcSEcCtD
Vincristine—Dizziness—Captopril—systemic scleroderma	0.000286	0.00113	CcSEcCtD
Vincristine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000285	0.00113	CcSEcCtD
Vincristine—Depression—Prednisone—systemic scleroderma	0.000285	0.00113	CcSEcCtD
Vincristine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000284	0.00113	CcSEcCtD
Vincristine—Body temperature increased—Leflunomide—systemic scleroderma	0.000282	0.00112	CcSEcCtD
Vincristine—Abdominal pain—Leflunomide—systemic scleroderma	0.000282	0.00112	CcSEcCtD
Vincristine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000282	0.00112	CcSEcCtD
Vincristine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00028	0.00111	CcSEcCtD
Vincristine—Myocardial infarction—Prednisone—systemic scleroderma	0.00028	0.00111	CcSEcCtD
Vincristine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.00028	0.00111	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000279	0.00111	CcSEcCtD
Vincristine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000278	0.0011	CcSEcCtD
Vincristine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000278	0.0011	CcSEcCtD
Vincristine—Insomnia—Lisinopril—systemic scleroderma	0.000277	0.0011	CcSEcCtD
Vincristine—Paraesthesia—Lisinopril—systemic scleroderma	0.000275	0.00109	CcSEcCtD
Vincristine—Vomiting—Captopril—systemic scleroderma	0.000275	0.00109	CcSEcCtD
Vincristine—Rash—Captopril—systemic scleroderma	0.000273	0.00108	CcSEcCtD
Vincristine—Dermatitis—Captopril—systemic scleroderma	0.000273	0.00108	CcSEcCtD
Vincristine—Headache—Captopril—systemic scleroderma	0.000271	0.00108	CcSEcCtD
Vincristine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000269	0.00107	CcSEcCtD
Vincristine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000269	0.00107	CcSEcCtD
Vincristine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000269	0.00106	CcSEcCtD
Vincristine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000269	0.00106	CcSEcCtD
Vincristine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000267	0.00106	CcSEcCtD
Vincristine—Decreased appetite—Lisinopril—systemic scleroderma	0.000267	0.00106	CcSEcCtD
Vincristine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000265	0.00105	CcSEcCtD
Vincristine—Fatigue—Lisinopril—systemic scleroderma	0.000264	0.00105	CcSEcCtD
Vincristine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000264	0.00104	CcSEcCtD
Vincristine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000263	0.00104	CcSEcCtD
Vincristine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000263	0.00104	CcSEcCtD
Vincristine—Constipation—Lisinopril—systemic scleroderma	0.000262	0.00104	CcSEcCtD
Vincristine—Pain—Lisinopril—systemic scleroderma	0.000262	0.00104	CcSEcCtD
Vincristine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00026	0.00103	CcSEcCtD
Vincristine—Diarrhoea—Azathioprine—systemic scleroderma	0.000259	0.00102	CcSEcCtD
Vincristine—Nausea—Captopril—systemic scleroderma	0.000257	0.00102	CcSEcCtD
Vincristine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000256	0.00102	CcSEcCtD
Vincristine—Asthenia—Leflunomide—systemic scleroderma	0.000256	0.00101	CcSEcCtD
Vincristine—Hallucination—Prednisone—systemic scleroderma	0.000255	0.00101	CcSEcCtD
Vincristine—Pancytopenia—Methotrexate—systemic scleroderma	0.000254	0.00101	CcSEcCtD
Vincristine—Connective tissue disorder—Prednisone—systemic scleroderma	0.000252	0.000998	CcSEcCtD
Vincristine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000251	0.000995	CcSEcCtD
Vincristine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000251	0.000994	CcSEcCtD
Vincristine—Dysuria—Methotrexate—systemic scleroderma	0.00025	0.000992	CcSEcCtD
Vincristine—Neutropenia—Methotrexate—systemic scleroderma	0.00025	0.000992	CcSEcCtD
Vincristine—Dizziness—Azathioprine—systemic scleroderma	0.00025	0.000991	CcSEcCtD
Vincristine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000247	0.000977	CcSEcCtD
Vincristine—ABCB1—lung—systemic scleroderma	0.000246	0.00313	CbGeAlD
Vincristine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000245	0.00097	CcSEcCtD
Vincristine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000244	0.000968	CcSEcCtD
Vincristine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000244	0.000968	CcSEcCtD
Vincristine—Diarrhoea—Leflunomide—systemic scleroderma	0.000244	0.000968	CcSEcCtD
Vincristine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000243	0.000963	CcSEcCtD
Vincristine—Abdominal pain—Lisinopril—systemic scleroderma	0.000242	0.000961	CcSEcCtD
Vincristine—Body temperature increased—Lisinopril—systemic scleroderma	0.000242	0.000961	CcSEcCtD
Vincristine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000241	0.000956	CcSEcCtD
Vincristine—Vomiting—Azathioprine—systemic scleroderma	0.00024	0.000952	CcSEcCtD
Vincristine—Pneumonia—Methotrexate—systemic scleroderma	0.00024	0.000951	CcSEcCtD
Vincristine—Rash—Azathioprine—systemic scleroderma	0.000238	0.000944	CcSEcCtD
Vincristine—Dermatitis—Azathioprine—systemic scleroderma	0.000238	0.000944	CcSEcCtD
Vincristine—Depression—Methotrexate—systemic scleroderma	0.000238	0.000943	CcSEcCtD
Vincristine—Headache—Azathioprine—systemic scleroderma	0.000237	0.000938	CcSEcCtD
Vincristine—Dizziness—Leflunomide—systemic scleroderma	0.000236	0.000935	CcSEcCtD
Vincristine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000234	0.000926	CcSEcCtD
Vincristine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000233	0.000923	CcSEcCtD
Vincristine—Stomatitis—Methotrexate—systemic scleroderma	0.000233	0.000922	CcSEcCtD
Vincristine—Angiopathy—Prednisone—systemic scleroderma	0.000233	0.000922	CcSEcCtD
Vincristine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000232	0.000919	CcSEcCtD
Vincristine—Pain—Mycophenolate mofetil—systemic scleroderma	0.00023	0.000911	CcSEcCtD
Vincristine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00023	0.000911	CcSEcCtD
Vincristine—Sweating—Methotrexate—systemic scleroderma	0.000229	0.000907	CcSEcCtD
Vincristine—Vomiting—Leflunomide—systemic scleroderma	0.000227	0.000899	CcSEcCtD
Vincristine—Alopecia—Prednisone—systemic scleroderma	0.000227	0.000898	CcSEcCtD
Vincristine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000226	0.000896	CcSEcCtD
Vincristine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000225	0.000892	CcSEcCtD
Vincristine—Rash—Leflunomide—systemic scleroderma	0.000225	0.000892	CcSEcCtD
Vincristine—Dermatitis—Leflunomide—systemic scleroderma	0.000225	0.000891	CcSEcCtD
Vincristine—Mental disorder—Prednisone—systemic scleroderma	0.000225	0.00089	CcSEcCtD
Vincristine—Nausea—Azathioprine—systemic scleroderma	0.000225	0.00089	CcSEcCtD
Vincristine—Headache—Leflunomide—systemic scleroderma	0.000224	0.000886	CcSEcCtD
Vincristine—Asthenia—Lisinopril—systemic scleroderma	0.00022	0.000872	CcSEcCtD
Vincristine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00022	0.000871	CcSEcCtD
Vincristine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000217	0.000858	CcSEcCtD
Vincristine—Rash—Mycophenolic acid—systemic scleroderma	0.000215	0.000851	CcSEcCtD
Vincristine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000215	0.00085	CcSEcCtD
Vincristine—Headache—Mycophenolic acid—systemic scleroderma	0.000213	0.000845	CcSEcCtD
Vincristine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000212	0.000842	CcSEcCtD
Vincristine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000212	0.000842	CcSEcCtD
Vincristine—Nausea—Leflunomide—systemic scleroderma	0.000212	0.00084	CcSEcCtD
Vincristine—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000212	0.000839	CcSEcCtD
Vincristine—Urethral disorder—Methotrexate—systemic scleroderma	0.00021	0.000832	CcSEcCtD
Vincristine—Diarrhoea—Lisinopril—systemic scleroderma	0.00021	0.000832	CcSEcCtD
Vincristine—Anaemia—Prednisone—systemic scleroderma	0.000206	0.000818	CcSEcCtD
Vincristine—Agitation—Prednisone—systemic scleroderma	0.000205	0.000813	CcSEcCtD
Vincristine—Dizziness—Lisinopril—systemic scleroderma	0.000203	0.000804	CcSEcCtD
Vincristine—Nausea—Mycophenolic acid—systemic scleroderma	0.000202	0.000802	CcSEcCtD
Vincristine—Vertigo—Prednisone—systemic scleroderma	0.000201	0.000795	CcSEcCtD
Vincristine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000199	0.000788	CcSEcCtD
Vincristine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000198	0.000785	CcSEcCtD
Vincristine—Vomiting—Lisinopril—systemic scleroderma	0.000195	0.000773	CcSEcCtD
Vincristine—Angiopathy—Methotrexate—systemic scleroderma	0.000194	0.00077	CcSEcCtD
Vincristine—Rash—Lisinopril—systemic scleroderma	0.000193	0.000766	CcSEcCtD
Vincristine—Convulsion—Prednisone—systemic scleroderma	0.000193	0.000766	CcSEcCtD
Vincristine—Dermatitis—Lisinopril—systemic scleroderma	0.000193	0.000766	CcSEcCtD
Vincristine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000193	0.000765	CcSEcCtD
Vincristine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000193	0.000764	CcSEcCtD
Vincristine—Hypertension—Prednisone—systemic scleroderma	0.000193	0.000764	CcSEcCtD
Vincristine—Headache—Lisinopril—systemic scleroderma	0.000192	0.000761	CcSEcCtD
Vincristine—Myalgia—Prednisone—systemic scleroderma	0.00019	0.000753	CcSEcCtD
Vincristine—Alopecia—Methotrexate—systemic scleroderma	0.000189	0.00075	CcSEcCtD
Vincristine—Mental disorder—Methotrexate—systemic scleroderma	0.000188	0.000744	CcSEcCtD
Vincristine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000184	0.000729	CcSEcCtD
Vincristine—Nausea—Lisinopril—systemic scleroderma	0.000182	0.000722	CcSEcCtD
Vincristine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000182	0.000722	CcSEcCtD
Vincristine—Oedema—Prednisone—systemic scleroderma	0.000182	0.000722	CcSEcCtD
Vincristine—Infection—Prednisone—systemic scleroderma	0.000181	0.000717	CcSEcCtD
Vincristine—Back pain—Methotrexate—systemic scleroderma	0.00018	0.000715	CcSEcCtD
Vincristine—Nervous system disorder—Prednisone—systemic scleroderma	0.000179	0.000708	CcSEcCtD
Vincristine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000178	0.000704	CcSEcCtD
Vincristine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000176	0.000698	CcSEcCtD
Vincristine—Anorexia—Prednisone—systemic scleroderma	0.000174	0.000688	CcSEcCtD
Vincristine—Anaemia—Methotrexate—systemic scleroderma	0.000172	0.000683	CcSEcCtD
Vincristine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000171	0.000677	CcSEcCtD
Vincristine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000169	0.000671	CcSEcCtD
Vincristine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000169	0.000671	CcSEcCtD
Vincristine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000168	0.000667	CcSEcCtD
Vincristine—Vertigo—Methotrexate—systemic scleroderma	0.000168	0.000664	CcSEcCtD
Vincristine—Leukopenia—Methotrexate—systemic scleroderma	0.000167	0.000662	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000166	0.000658	CcSEcCtD
Vincristine—Insomnia—Prednisone—systemic scleroderma	0.000165	0.000653	CcSEcCtD
Vincristine—Paraesthesia—Prednisone—systemic scleroderma	0.000164	0.000648	CcSEcCtD
Vincristine—Convulsion—Methotrexate—systemic scleroderma	0.000162	0.00064	CcSEcCtD
Vincristine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00016	0.000633	CcSEcCtD
Vincristine—Myalgia—Methotrexate—systemic scleroderma	0.000159	0.000629	CcSEcCtD
Vincristine—Decreased appetite—Prednisone—systemic scleroderma	0.000158	0.000628	CcSEcCtD
Vincristine—Fatigue—Prednisone—systemic scleroderma	0.000157	0.000622	CcSEcCtD
Vincristine—Constipation—Prednisone—systemic scleroderma	0.000156	0.000617	CcSEcCtD
Vincristine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000152	0.000603	CcSEcCtD
Vincristine—Infection—Methotrexate—systemic scleroderma	0.000151	0.000599	CcSEcCtD
Vincristine—Nervous system disorder—Methotrexate—systemic scleroderma	0.000149	0.000592	CcSEcCtD
Vincristine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000149	0.000591	CcSEcCtD
Vincristine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000149	0.00059	CcSEcCtD
Vincristine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000147	0.000583	CcSEcCtD
Vincristine—Anorexia—Methotrexate—systemic scleroderma	0.000145	0.000575	CcSEcCtD
Vincristine—Body temperature increased—Prednisone—systemic scleroderma	0.000144	0.000571	CcSEcCtD
Vincristine—Abdominal pain—Prednisone—systemic scleroderma	0.000144	0.000571	CcSEcCtD
Vincristine—Hypotension—Methotrexate—systemic scleroderma	0.000142	0.000564	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000139	0.00055	CcSEcCtD
Vincristine—Insomnia—Methotrexate—systemic scleroderma	0.000138	0.000546	CcSEcCtD
Vincristine—Paraesthesia—Methotrexate—systemic scleroderma	0.000137	0.000542	CcSEcCtD
Vincristine—Hypersensitivity—Prednisone—systemic scleroderma	0.000134	0.000532	CcSEcCtD
Vincristine—Decreased appetite—Methotrexate—systemic scleroderma	0.000132	0.000524	CcSEcCtD
Vincristine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000131	0.000521	CcSEcCtD
Vincristine—Fatigue—Methotrexate—systemic scleroderma	0.000131	0.00052	CcSEcCtD
Vincristine—Asthenia—Prednisone—systemic scleroderma	0.000131	0.000518	CcSEcCtD
Vincristine—Pain—Methotrexate—systemic scleroderma	0.00013	0.000516	CcSEcCtD
Vincristine—Diarrhoea—Prednisone—systemic scleroderma	0.000125	0.000494	CcSEcCtD
Vincristine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000124	0.000493	CcSEcCtD
Vincristine—Dizziness—Prednisone—systemic scleroderma	0.00012	0.000477	CcSEcCtD
Vincristine—Abdominal pain—Methotrexate—systemic scleroderma	0.00012	0.000477	CcSEcCtD
Vincristine—Body temperature increased—Methotrexate—systemic scleroderma	0.00012	0.000477	CcSEcCtD
Vincristine—Vomiting—Prednisone—systemic scleroderma	0.000116	0.000459	CcSEcCtD
Vincristine—Rash—Prednisone—systemic scleroderma	0.000115	0.000455	CcSEcCtD
Vincristine—Dermatitis—Prednisone—systemic scleroderma	0.000115	0.000455	CcSEcCtD
Vincristine—Headache—Prednisone—systemic scleroderma	0.000114	0.000452	CcSEcCtD
Vincristine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000112	0.000444	CcSEcCtD
Vincristine—Asthenia—Methotrexate—systemic scleroderma	0.000109	0.000433	CcSEcCtD
Vincristine—Nausea—Prednisone—systemic scleroderma	0.000108	0.000429	CcSEcCtD
Vincristine—Diarrhoea—Methotrexate—systemic scleroderma	0.000104	0.000413	CcSEcCtD
Vincristine—Dizziness—Methotrexate—systemic scleroderma	0.000101	0.000399	CcSEcCtD
Vincristine—Vomiting—Methotrexate—systemic scleroderma	9.68e-05	0.000384	CcSEcCtD
Vincristine—Rash—Methotrexate—systemic scleroderma	9.6e-05	0.00038	CcSEcCtD
Vincristine—Dermatitis—Methotrexate—systemic scleroderma	9.59e-05	0.00038	CcSEcCtD
Vincristine—Headache—Methotrexate—systemic scleroderma	9.54e-05	0.000378	CcSEcCtD
Vincristine—Nausea—Methotrexate—systemic scleroderma	9.04e-05	0.000358	CcSEcCtD
